Analysts at Sidoti downgraded Ballard Power Systems Inc. (BLDP) from ‘Buy‘ to ‘Neutral‘ in a research report issued to clients on Thursday.
On valuation measures, Ballard Power Systems stock is trading at a P/E to growth and price-to-sales ratio of (666.67) and 5.14, respectively. The t-12-month revenue at Ballard Power Systems Inc. is $70.39 million. BLDP ‘s ROE for the same period is (18.62%).
Shares of the $318.37 million market cap company are down 6.48% year-over-year ; up 38.38% year-to-date.
BLDP, currently with a median Wall Street price target of $3.00 and a high target of $4.00, dropped $0.34 to $2.40 in recent trading.
The chart below shows where the equity has traded over the past 52-weeks.
Nationstar Mortgage Holdings Inc. (NSM) was downgraded from ‘Buy‘ to ‘Neutral‘ at Sterne Agee.
Shares have traded today between $26.50 and $29.00 with the price of the stock fluctuating between $22.94 to $37.95 over the last 52 weeks.
Nationstar Mortgage Holdings Inc. shares are currently changing hands at 17.05x this year’s forecasted earnings, compared to the industry’s 17.92x earnings multiple. Ticker has a t-12 price/sales ratio of 2.06. EPS for the same period registers at $1.66.
Shares of NSM have lost $3.04 to $28.25 in mid-day trading on Thursday, giving it a market cap of roughly $2.55 billion. The stock traded as high as $37.95 in June 6, 2014.
Morgan Stanley (MS) reported on Thursday that they have lowered their rating for Abercrombie & Fitch Co. (ANF). The firm has downgraded ANF from ‘Equal-Weight‘ to ‘Underweight‘ .
As for passive income investors, the company pays shareholders $0.80 per share annually in dividends, yielding 3.10%. Five year average dividend yield currently stands at 1.80%.
Abercrombie & Fitch Co. recently traded at $23.87, a loss of $0.99 over Wednesday’s closing price. The name has a current market capitalization of $1.66 billion.
Pharmacyclics Inc. (PCYC) had its rating lowered from ‘Buy‘ to ‘Hold‘ by analysts at WallachBeth on Thursday. The firm sees shares as fairly valued at $228, versus $220.22 close. Currently there are 13 analysts that rate PCYC a ‘Buy’, no analysts rate it a ‘Sell’, and 7 rate it a ‘Hold’.
PCYC was down $8.42 at $211.80 in mid-day trade, moving within a 52-week range of $82.51 to $231.09. The name, valued at $16.38 billion, opened at $218.44.
On valuation measures, Pharmacyclics Inc. shares are currently priced at 194.18x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 22.94. EPS for the same period registers at $1.11.
The TJX Companies, Inc. (TJX) was downgraded by MKM Partners from a ‘Buy‘ rating to a ‘Neutral’ rating in a research report issued to clients on Thursday. The firm currently has a $68 price objective on the stock, six points lower from their previous price target.
TJX closed at $69.38 on Wednesday and is currently trading down $0.42.
In the past 52 weeks, shares of the apparel and home fashions retailer have traded between a low of $51.91 and a high of $69.87 and are now trading at $68.96. Shares are up 15.08% year-over-year and 1.43% year-to-date.